Best Agrolife has reported 103 per cent jump in its Revenue to Rs. 274.3 crore in Q4 FY25 as compared to Rs. 135.4 crore in Q4 FY24. For FY25, Best Agrolife reported the Revenue of Rs. 1,814.3 crore as compared to Rs. 1,873.3 crore, drop of 3 per cent.

Commenting on the result and overall update on the FY'2024-25, Vimal Kumar, Managing Director, Best Agrolife Ltd, said, "We are pleased to share the improved performance in Q4 FY25 having brought a turnaround in our financial and operational performance. Our concerted efforts towards cost optimization, strategic restructuring, and improved operational efficiency and brand business have led to a reduction in losses from Rs. 92 crore in Q4 FY24 to Rs. 24 crore this quarter.

We believe that our improved gross margins and reduced operating expenses reflect our disciplined approach and commitment to sustainable growth. With better inventory management, have reduced our inventory position by Rs. 185 crore (19 % YoY) and streamlined working capital by Rs. 146 crore (54% YoY). We've notably strengthened our operating cash flow position to Rs. 192 crore (540 % YoY) and reduced our total borrowings by Rs. 161 crore (25% YoY).

In business operations, sales return has been a major concern for us. For FY25-26, we have introduced a strategic sales policy for driving demand in specialty products and ensuring significant reduction in sales returns. This will help drive profitability and accountability across the sales channels.

Key strategic initiatives such as the geographic brand restructuring and targeted team realignment have already started yielding results in terms of efficiency and market responsiveness.

Furthermore, the technical plant expansion is a key milestone for us, with Rs. Rs60 crore of funding sanctioned towards the Rs. 90 crore project. This capex initiative will support future capacity expansion and reinforce our production capabilities for newer technicals.

We are keeping up with our commitment of delivering 3 to 4 cutting edge patented crop protection solutions tailored to the needs of Indian agriculture every year.

After receiving positive feedback from farmers across India during extensive trials and demonstrations we have officially launched our patented herbicide "Shot Down" (Haloxyfop-R-Methyl 12.8% + lmazethapyr 10% ME) in the Indian market. Building on this momentum, we are excited to announce the upcoming launch of two more patented products - "Bestman" (Fipronil 7.0% + Abamectin 1.25% + Tolfenpyrad 15% SC) and "Fetagen" (Chlorantraniliprole 0.45% + Emamectin Benzoate 0.18% + Fipronil 0.50% GR). Further, we will be launching an exciting range of Biopesticides in FY26. These products represent the next wave of our research driven approach and are designed to support farmers in achieving higher yields and sustainable farming practices.

We continue to strategically expand our R&D capabilities, with promising returns anticipated in the coming years. Our commitment remains strong toward developing safer, more innovative chemistries that benefit both farmers and the environment. Looking ahead, we are focused on driving sustainable growth, enhancing operational excellence, and delivering long-term value for our stakeholders.

Continuing our tradition, we are happy to declare a dividend of Rs. 3 per share subject to approval of the shareholders."